1148 related articles for article (PubMed ID: 26490331)
1. Olesoxime suppresses calpain activation and mutant huntingtin fragmentation in the BACHD rat.
Clemens LE; Weber JJ; Wlodkowski TT; Yu-Taeger L; Michaud M; Calaminus C; Eckert SH; Gaca J; Weiss A; Magg JC; Jansson EK; Eckert GP; Pichler BJ; Bordet T; Pruss RM; Riess O; Nguyen HP
Brain; 2015 Dec; 138(Pt 12):3632-53. PubMed ID: 26490331
[TBL] [Abstract][Full Text] [Related]
2. The calpain-suppressing effects of olesoxime in Huntington's disease.
Weber JJ; Ortiz Rios MM; Riess O; Clemens LE; Nguyen HP
Rare Dis; 2016; 4(1):e1153778. PubMed ID: 27141414
[TBL] [Abstract][Full Text] [Related]
3. Mitochondrial membrane fluidity is consistently increased in different models of Huntington disease: restorative effects of olesoxime.
Eckmann J; Clemens LE; Eckert SH; Hagl S; Yu-Taeger L; Bordet T; Pruss RM; Muller WE; Leuner K; Nguyen HP; Eckert GP
Mol Neurobiol; 2014 Aug; 50(1):107-18. PubMed ID: 24633813
[TBL] [Abstract][Full Text] [Related]
4. Olesoxime in neurodegenerative diseases: Scrutinising a promising drug candidate.
Weber JJ; Clemensson LE; Schiöth HB; Nguyen HP
Biochem Pharmacol; 2019 Oct; 168():305-318. PubMed ID: 31283931
[TBL] [Abstract][Full Text] [Related]
5. Full-length human mutant huntingtin with a stable polyglutamine repeat can elicit progressive and selective neuropathogenesis in BACHD mice.
Gray M; Shirasaki DI; Cepeda C; André VM; Wilburn B; Lu XH; Tao J; Yamazaki I; Li SH; Sun YE; Li XJ; Levine MS; Yang XW
J Neurosci; 2008 Jun; 28(24):6182-95. PubMed ID: 18550760
[TBL] [Abstract][Full Text] [Related]
6. Caspase 3-cleaved N-terminal fragments of wild-type and mutant huntingtin are present in normal and Huntington's disease brains, associate with membranes, and undergo calpain-dependent proteolysis.
Kim YJ; Yi Y; Sapp E; Wang Y; Cuiffo B; Kegel KB; Qin ZH; Aronin N; DiFiglia M
Proc Natl Acad Sci U S A; 2001 Oct; 98(22):12784-9. PubMed ID: 11675509
[TBL] [Abstract][Full Text] [Related]
7. Calpain activation in Huntington's disease.
Gafni J; Ellerby LM
J Neurosci; 2002 Jun; 22(12):4842-9. PubMed ID: 12077181
[TBL] [Abstract][Full Text] [Related]
8. Calpastatin ablation aggravates the molecular phenotype in cell and animal models of Huntington disease.
Weber JJ; Kloock SJ; Nagel M; Ortiz-Rios MM; Hofmann J; Riess O; Nguyen HP
Neuropharmacology; 2018 May; 133():94-106. PubMed ID: 29355642
[TBL] [Abstract][Full Text] [Related]
9. Calpain is a major cell death effector in selective striatal degeneration induced in vivo by 3-nitropropionate: implications for Huntington's disease.
Bizat N; Hermel JM; Boyer F; Jacquard C; Créminon C; Ouary S; Escartin C; Hantraye P; Kajewski S; Brouillet E
J Neurosci; 2003 Jun; 23(12):5020-30. PubMed ID: 12832525
[TBL] [Abstract][Full Text] [Related]
10. A Huntingtin-based peptide inhibitor of caspase-6 provides protection from mutant Huntingtin-induced motor and behavioral deficits.
Aharony I; Ehrnhoefer DE; Shruster A; Qiu X; Franciosi S; Hayden MR; Offen D
Hum Mol Genet; 2015 May; 24(9):2604-14. PubMed ID: 25616965
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of calpain cleavage of huntingtin reduces toxicity: accumulation of calpain/caspase fragments in the nucleus.
Gafni J; Hermel E; Young JE; Wellington CL; Hayden MR; Ellerby LM
J Biol Chem; 2004 May; 279(19):20211-20. PubMed ID: 14981075
[TBL] [Abstract][Full Text] [Related]
12. Caspase-6 activity in a BACHD mouse modulates steady-state levels of mutant huntingtin protein but is not necessary for production of a 586 amino acid proteolytic fragment.
Gafni J; Papanikolaou T; Degiacomo F; Holcomb J; Chen S; Menalled L; Kudwa A; Fitzpatrick J; Miller S; Ramboz S; Tuunanen PI; Lehtimäki KK; Yang XW; Park L; Kwak S; Howland D; Park H; Ellerby LM
J Neurosci; 2012 May; 32(22):7454-65. PubMed ID: 22649225
[TBL] [Abstract][Full Text] [Related]
13. Progressive phenotype and nuclear accumulation of an amino-terminal cleavage fragment in a transgenic mouse model with inducible expression of full-length mutant huntingtin.
Tanaka Y; Igarashi S; Nakamura M; Gafni J; Torcassi C; Schilling G; Crippen D; Wood JD; Sawa A; Jenkins NA; Copeland NG; Borchelt DR; Ross CA; Ellerby LM
Neurobiol Dis; 2006 Feb; 21(2):381-91. PubMed ID: 16150600
[TBL] [Abstract][Full Text] [Related]
14. Increased Steady-State Mutant Huntingtin mRNA in Huntington's Disease Brain.
Liu W; Chaurette J; Pfister EL; Kennington LA; Chase KO; Bullock J; Vonsattel JP; Faull RL; Macdonald D; DiFiglia M; Zamore PD; Aronin N
J Huntingtons Dis; 2013; 2(4):491-500. PubMed ID: 25062733
[TBL] [Abstract][Full Text] [Related]
15. Mutant huntingtin aggregates impair mitochondrial movement and trafficking in cortical neurons.
Chang DT; Rintoul GL; Pandipati S; Reynolds IJ
Neurobiol Dis; 2006 May; 22(2):388-400. PubMed ID: 16473015
[TBL] [Abstract][Full Text] [Related]
16. N-terminal mutant huntingtin associates with mitochondria and impairs mitochondrial trafficking.
Orr AL; Li S; Wang CE; Li H; Wang J; Rong J; Xu X; Mastroberardino PG; Greenamyre JT; Li XJ
J Neurosci; 2008 Mar; 28(11):2783-92. PubMed ID: 18337408
[TBL] [Abstract][Full Text] [Related]
17. Sensitive biochemical aggregate detection reveals aggregation onset before symptom development in cellular and murine models of Huntington's disease.
Weiss A; Klein C; Woodman B; Sathasivam K; Bibel M; Régulier E; Bates GP; Paganetti P
J Neurochem; 2008 Feb; 104(3):846-58. PubMed ID: 17986219
[TBL] [Abstract][Full Text] [Related]
18. Cellular and subcellular localization of Huntingtin [corrected] aggregates in the brain of a rat transgenic for Huntington disease.
Petrasch-Parwez E; Nguyen HP; Löbbecke-Schumacher M; Habbes HW; Wieczorek S; Riess O; Andres KH; Dermietzel R; Von Hörsten S
J Comp Neurol; 2007 Apr; 501(5):716-30. PubMed ID: 17299753
[TBL] [Abstract][Full Text] [Related]
19. Mutant huntingtin and glycogen synthase kinase 3-beta accumulate in neuronal lipid rafts of a presymptomatic knock-in mouse model of Huntington's disease.
Valencia A; Reeves PB; Sapp E; Li X; Alexander J; Kegel KB; Chase K; Aronin N; DiFiglia M
J Neurosci Res; 2010 Jan; 88(1):179-90. PubMed ID: 19642201
[TBL] [Abstract][Full Text] [Related]
20. Huntington disease and the huntingtin protein.
Zheng Z; Diamond MI
Prog Mol Biol Transl Sci; 2012; 107():189-214. PubMed ID: 22482451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]